Skip to main content
Erschienen in: Digestive Diseases and Sciences 5/2020

15.10.2019 | Original Article

Diagnostic Utility of Carbohydrate Breath Tests for SIBO, Fructose, and Lactose Intolerance

verfasst von: Mercedes Amieva-Balmori, Enrique Coss-Adame, Nikilesh S. Rao, Brisa M. Dávalos-Pantoja, Satish S. C. Rao

Erschienen in: Digestive Diseases and Sciences | Ausgabe 5/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Unexplained bloating, gas, and pain are common symptoms. If routine tests are negative, such patients are often labeled as irritable bowel syndrome.

Aims

To determine the diagnostic utility of breath tests that assess for small intestinal bacterial overgrowth (SIBO), fructose or lactose intolerance, and the predictive value of symptoms.

Methods

Patients with gas, bloating, diarrhea, abdominal pain (≥ 6 months), and negative endoscopy and radiology tests were assessed with symptom questionnaires, glucose (75 g), fructose (25 g), or lactose (25 g) breath tests. Breath tests were categorized as positive when H2 (≥ 20 ppm) or CH4 (≥ 15 ppm) increased above baseline values or as hypersensitive when symptoms changed significantly without rise in H2/CH4 or as negative.

Results

1230 patients (females = 878) underwent 2236 breath tests. The prevalence of SIBO was 33% (294/883), fructose intolerance was 34% (262/763), and lactose intolerance was 44% (260/590). Hypersensitivity was found in 16% and 9%, respectively, during fructose and lactose breath tests. Although gas (89%), abdominal pain (82%), and bloating (82%) were highly prevalent, pretest symptoms or their severity did not predict an abnormal breath test, but symptoms during the breath test facilitated diagnosis of SIBO, fructose, and lactose intolerance and hypersensitivity.

Conclusions

Approximately 45% of patients with unexplained gas and bloating had SIBO, fructose, or lactose intolerance; another 9–16% had visceral hypersensitivity. Pretest symptoms were poor predictors, but symptoms during the breath tests were useful. Breath tests are safe, provide significant diagnostic yield, and could be useful in routine gastroenterology practice.
Literatur
1.
Zurück zum Zitat Goebel-Stengel M, Stengel A, Schmidtmann M, et al. Unclear abdominal discomfort: pivotal role of carbohydrate malabsorption. J Neurogastroenterol Motil. 2014;20:228–235.PubMedPubMedCentral Goebel-Stengel M, Stengel A, Schmidtmann M, et al. Unclear abdominal discomfort: pivotal role of carbohydrate malabsorption. J Neurogastroenterol Motil. 2014;20:228–235.PubMedPubMedCentral
2.
Zurück zum Zitat Ringel Y, Williams RE, Kalilani L, et al. Prevalence, characteristics, and impact of bloating symptoms in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol. 2009;7:68–72.PubMed Ringel Y, Williams RE, Kalilani L, et al. Prevalence, characteristics, and impact of bloating symptoms in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol. 2009;7:68–72.PubMed
4.
Zurück zum Zitat Fernandez-Banares F, Esteve-Pardo M, de Leon R, et al. Sugar malabsorption in functional bowel disease: clinical implications. Am J Gastroenterol. 1993;88:2044–2050.PubMed Fernandez-Banares F, Esteve-Pardo M, de Leon R, et al. Sugar malabsorption in functional bowel disease: clinical implications. Am J Gastroenterol. 1993;88:2044–2050.PubMed
5.
Zurück zum Zitat Chang L. Review article: epidemiology and quality of life in functional gastrointestinal disorders. Aliment Pharmacol Ther. 2004;20:31–39.PubMed Chang L. Review article: epidemiology and quality of life in functional gastrointestinal disorders. Aliment Pharmacol Ther. 2004;20:31–39.PubMed
6.
Zurück zum Zitat Drossman DA, Morris CB, Schneck S, et al. International survey of patients with IBS: symptom features and their severity, health status, treatments, and risk taking to achieve clinical benefit. J Clin Gastroenterol. 2009;43:541–550.PubMedPubMedCentral Drossman DA, Morris CB, Schneck S, et al. International survey of patients with IBS: symptom features and their severity, health status, treatments, and risk taking to achieve clinical benefit. J Clin Gastroenterol. 2009;43:541–550.PubMedPubMedCentral
7.
Zurück zum Zitat Chang L, Toner BB, Fukudo S, et al. Gender, age, society, culture, and the patient’s perspective in the functional gastrointestinal disorders. Gastroenterology. 2006;130:1435–1446.PubMed Chang L, Toner BB, Fukudo S, et al. Gender, age, society, culture, and the patient’s perspective in the functional gastrointestinal disorders. Gastroenterology. 2006;130:1435–1446.PubMed
8.
Zurück zum Zitat Riveros MJ, Parada A, Pettinelli P. Fructose consumption and its health implications; fructose malabsorption and nonalcoholic fatty liver disease. Nutr Hosp. 2014;29:491–499.PubMed Riveros MJ, Parada A, Pettinelli P. Fructose consumption and its health implications; fructose malabsorption and nonalcoholic fatty liver disease. Nutr Hosp. 2014;29:491–499.PubMed
9.
Zurück zum Zitat Vos MB, Kimmons JE, Gillespie C, et al. Dietary fructose consumption among US children and adults: the Third National Health and Nutrition Examination Survey. Medscape J Med. 2008;10:160.PubMedPubMedCentral Vos MB, Kimmons JE, Gillespie C, et al. Dietary fructose consumption among US children and adults: the Third National Health and Nutrition Examination Survey. Medscape J Med. 2008;10:160.PubMedPubMedCentral
10.
Zurück zum Zitat Bray GA. Energy and fructose from beverages sweetened with sugar or high-fructose corn syrup pose a health risk for some people. Adv Nutr. 2013;4:220–225.PubMedPubMedCentral Bray GA. Energy and fructose from beverages sweetened with sugar or high-fructose corn syrup pose a health risk for some people. Adv Nutr. 2013;4:220–225.PubMedPubMedCentral
11.
Zurück zum Zitat Rao SS, Attaluri A, Anderson L, et al. Ability of the normal human small intestine to absorb fructose: evaluation by breath testing. Clin Gastroenterol Hepatol. 2007;5:959–963.PubMedPubMedCentral Rao SS, Attaluri A, Anderson L, et al. Ability of the normal human small intestine to absorb fructose: evaluation by breath testing. Clin Gastroenterol Hepatol. 2007;5:959–963.PubMedPubMedCentral
13.
Zurück zum Zitat Wasserman D, Hoekstra JH, Tolia V, et al. Molecular analysis of the fructose transporter gene (GLUT5) in isolated fructose malabsorption. J Clin Invest. 1996;98:2398–2402.PubMedPubMedCentral Wasserman D, Hoekstra JH, Tolia V, et al. Molecular analysis of the fructose transporter gene (GLUT5) in isolated fructose malabsorption. J Clin Invest. 1996;98:2398–2402.PubMedPubMedCentral
14.
Zurück zum Zitat Corpe CP, Bovelander FJ, Hoekstra JH, et al. The small intestinal fructose transporters: site of dietary perception and evidence for diurnal and fructose sensitive control elements. Biochim Biophys Acta. 1998;1402:229–238.PubMed Corpe CP, Bovelander FJ, Hoekstra JH, et al. The small intestinal fructose transporters: site of dietary perception and evidence for diurnal and fructose sensitive control elements. Biochim Biophys Acta. 1998;1402:229–238.PubMed
15.
Zurück zum Zitat Biesiekierski JR. Fructose-induced symptoms beyond malabsorption in FGID. United European Gastroenterol J. 2014;2:10–13.PubMedPubMedCentral Biesiekierski JR. Fructose-induced symptoms beyond malabsorption in FGID. United European Gastroenterol J. 2014;2:10–13.PubMedPubMedCentral
16.
Zurück zum Zitat Choi YK, Johlin FC Jr, Summers RW, et al. Fructose intolerance: an under-recognized problem. Am J Gastroenterol. 2003;98:1348–1353.PubMed Choi YK, Johlin FC Jr, Summers RW, et al. Fructose intolerance: an under-recognized problem. Am J Gastroenterol. 2003;98:1348–1353.PubMed
17.
Zurück zum Zitat Choi YK, Kraft N, Zimmerman B, et al. Fructose intolerance in IBS and utility of fructose-restricted diet. J Clin Gastroenterol. 2008;42:233–238.PubMed Choi YK, Kraft N, Zimmerman B, et al. Fructose intolerance in IBS and utility of fructose-restricted diet. J Clin Gastroenterol. 2008;42:233–238.PubMed
18.
Zurück zum Zitat Di Rienzo T, D’Angelo G, D’Aversa F, et al. Lactose intolerance: from diagnosis to correct management. Eur Rev Med Pharmacol Sci. 2013;17:18–25.PubMed Di Rienzo T, D’Angelo G, D’Aversa F, et al. Lactose intolerance: from diagnosis to correct management. Eur Rev Med Pharmacol Sci. 2013;17:18–25.PubMed
19.
Zurück zum Zitat United States Department of Agriculture. Economic Research Service. Dairy products; Per Capita Availability/dymfg.xls. United States Department of Agriculture. Economic Research Service. Dairy products; Per Capita Availability/dymfg.xls.
20.
Zurück zum Zitat Deng Y, Misselwitz B, Dai N, et al. Lactose intolerance in adults: biological mechanism and dietary management. Nutrients. 2015;7:8020–8035.PubMedPubMedCentral Deng Y, Misselwitz B, Dai N, et al. Lactose intolerance in adults: biological mechanism and dietary management. Nutrients. 2015;7:8020–8035.PubMedPubMedCentral
21.
Zurück zum Zitat Scrimshaw NS, Murray EB. The acceptability of milk and milk products in populations with a high prevalence of lactose intolerance. Am J Clin Nutr. 1988;48:1079–1159.PubMed Scrimshaw NS, Murray EB. The acceptability of milk and milk products in populations with a high prevalence of lactose intolerance. Am J Clin Nutr. 1988;48:1079–1159.PubMed
22.
Zurück zum Zitat Vesa TH, Marteau P, Korpela R. Lactose intolerance. J Am Coll Nutr. 2000;19:165S–175S.PubMed Vesa TH, Marteau P, Korpela R. Lactose intolerance. J Am Coll Nutr. 2000;19:165S–175S.PubMed
23.
Zurück zum Zitat Erdogan A, Rao SS, Gulley D, et al. Small intestinal bacterial overgrowth: duodenal aspiration vs glucose breath test. Neurogastroenterol Motil. 2015;27:481–489.PubMed Erdogan A, Rao SS, Gulley D, et al. Small intestinal bacterial overgrowth: duodenal aspiration vs glucose breath test. Neurogastroenterol Motil. 2015;27:481–489.PubMed
24.
Zurück zum Zitat Ghoshal UC, Ghoshal U. Small intestinal bacterial overgrowth and other intestinal disorders. Gastroenterol Clin North Am. 2017;46:103–120.PubMed Ghoshal UC, Ghoshal U. Small intestinal bacterial overgrowth and other intestinal disorders. Gastroenterol Clin North Am. 2017;46:103–120.PubMed
25.
Zurück zum Zitat Rezaie A, Pimentel M, Rao SS. How to test and treat small intestinal bacterial overgrowth: an evidence-based approach. Curr Gastroenterol Rep. 2016;18:8.PubMed Rezaie A, Pimentel M, Rao SS. How to test and treat small intestinal bacterial overgrowth: an evidence-based approach. Curr Gastroenterol Rep. 2016;18:8.PubMed
26.
Zurück zum Zitat Rezaie A, Buresi M, Lembo A, et al. Hydrogen and methane-based breath testing in gastrointestinal disorders: the North American consensus. Am J Gastroenterol. 2017;112:775–784.PubMedPubMedCentral Rezaie A, Buresi M, Lembo A, et al. Hydrogen and methane-based breath testing in gastrointestinal disorders: the North American consensus. Am J Gastroenterol. 2017;112:775–784.PubMedPubMedCentral
27.
Zurück zum Zitat Montalto M, Gallo A, Ojetti V, et al. Fructose, trehalose and sorbitol malabsorption. Eur Rev Med Pharmacol Sci. 2013;17:26–29.PubMed Montalto M, Gallo A, Ojetti V, et al. Fructose, trehalose and sorbitol malabsorption. Eur Rev Med Pharmacol Sci. 2013;17:26–29.PubMed
28.
Zurück zum Zitat Misselwitz B, Pohl D, Fruhauf H, et al. Lactose malabsorption and intolerance: pathogenesis, diagnosis and treatment. United Eur Gastroenterol J. 2013;1:151–159. Misselwitz B, Pohl D, Fruhauf H, et al. Lactose malabsorption and intolerance: pathogenesis, diagnosis and treatment. United Eur Gastroenterol J. 2013;1:151–159.
29.
30.
Zurück zum Zitat Christman NT, Hamilton LH. A new chromatographic instrument for measuring trace concentrations of breath-hydrogen. J Chromatogr. 1982;229:259–265.PubMed Christman NT, Hamilton LH. A new chromatographic instrument for measuring trace concentrations of breath-hydrogen. J Chromatogr. 1982;229:259–265.PubMed
31.
Zurück zum Zitat Gasbarrini A, Corazza GR, Gasbarrini G, et al. Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference. Aliment Pharmacol Ther. 2009;29:1–49.PubMed Gasbarrini A, Corazza GR, Gasbarrini G, et al. Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference. Aliment Pharmacol Ther. 2009;29:1–49.PubMed
32.
Zurück zum Zitat Lacy BE, Mearin F, Chang L, et al. Bowel disorders. Gastroenterology. 2016;150:1393–1407. Lacy BE, Mearin F, Chang L, et al. Bowel disorders. Gastroenterology. 2016;150:1393–1407.
33.
Zurück zum Zitat Gibson PR. History of the low FODMAP diet. J Gastroenterol Hepatol. 2017;32:5–7.PubMed Gibson PR. History of the low FODMAP diet. J Gastroenterol Hepatol. 2017;32:5–7.PubMed
34.
Zurück zum Zitat Srigley JA, Brooks A, Sung M, et al. Inappropriate use of antibiotics and Clostridium difficile infection. Am J Infect Control. 2013;41:1116–1118.PubMed Srigley JA, Brooks A, Sung M, et al. Inappropriate use of antibiotics and Clostridium difficile infection. Am J Infect Control. 2013;41:1116–1118.PubMed
35.
Zurück zum Zitat Sloan TJ, Jalanka J, Major GAD, et al. A low FODMAP diet is associated with changes in the microbiota and reduction in breath hydrogen but not colonic volume in healthy subjects. PLoS ONE. 2018;13:e0201410.PubMedPubMedCentral Sloan TJ, Jalanka J, Major GAD, et al. A low FODMAP diet is associated with changes in the microbiota and reduction in breath hydrogen but not colonic volume in healthy subjects. PLoS ONE. 2018;13:e0201410.PubMedPubMedCentral
36.
Zurück zum Zitat Rao SS, Yu S, Fedewa A. Systematic review: dietary fibre and FODMAP-restricted diet in the management of constipation and irritable bowel syndrome. Aliment Pharmacol Ther. 2015;41:1256–1270.PubMed Rao SS, Yu S, Fedewa A. Systematic review: dietary fibre and FODMAP-restricted diet in the management of constipation and irritable bowel syndrome. Aliment Pharmacol Ther. 2015;41:1256–1270.PubMed
38.
Zurück zum Zitat Dionne J, Ford AC, Yuan Y, et al. A systematic review and meta-analysis evaluating the efficacy of a gluten-free diet and alow FODMAPs diet in treating symptoms of irritable bowel syndrome. Am J Gastroenterol. 2018;113:1290–1300.PubMed Dionne J, Ford AC, Yuan Y, et al. A systematic review and meta-analysis evaluating the efficacy of a gluten-free diet and alow FODMAPs diet in treating symptoms of irritable bowel syndrome. Am J Gastroenterol. 2018;113:1290–1300.PubMed
39.
Zurück zum Zitat Pimentel M, Gunsalus RP, Rao SS, et al. Methanogens in human health and disease. Am J Gastroenterol. 2012;1:28–33. Pimentel M, Gunsalus RP, Rao SS, et al. Methanogens in human health and disease. Am J Gastroenterol. 2012;1:28–33.
40.
Zurück zum Zitat Saad RJ, Chey WD. Breath testing for small intestinal bacterial overgrowth: maximizing test accuracy. Clin Gastroenterol Hepatol. 2014;12:1964–1972.PubMed Saad RJ, Chey WD. Breath testing for small intestinal bacterial overgrowth: maximizing test accuracy. Clin Gastroenterol Hepatol. 2014;12:1964–1972.PubMed
41.
Zurück zum Zitat Lin ESK, Pichetshote N, et al. Measurement of hydrogen sulfide during breath testing correlates to patient symptoms. Gastroenterol. 2017;152:S205–S206. Lin ESK, Pichetshote N, et al. Measurement of hydrogen sulfide during breath testing correlates to patient symptoms. Gastroenterol. 2017;152:S205–S206.
42.
Zurück zum Zitat Singer-Englar T, Rezaie A, Gupta K, et al. Competitive hydrogen gas utilization by methane- and hydrogen sulfide-producing microorganisms and associated symptoms: results of a novel 4-gas breath test machine. Gastroenterology. 2018;154:S-47. Singer-Englar T, Rezaie A, Gupta K, et al. Competitive hydrogen gas utilization by methane- and hydrogen sulfide-producing microorganisms and associated symptoms: results of a novel 4-gas breath test machine. Gastroenterology. 2018;154:S-47.
43.
Zurück zum Zitat Zhu Y, Zheng X, Cong Y, et al. Bloating and distention in irritable bowel syndrome: the role of gas production and visceral sensation after lactose ingestion in a population with lactase deficiency. Am J Gastroenterol. 2013;108:1516–1525.PubMed Zhu Y, Zheng X, Cong Y, et al. Bloating and distention in irritable bowel syndrome: the role of gas production and visceral sensation after lactose ingestion in a population with lactase deficiency. Am J Gastroenterol. 2013;108:1516–1525.PubMed
44.
Zurück zum Zitat Dainese R, Casellas F, Marine-Barjoan E, et al. Perception of lactose intolerance in irritable bowel syndrome patients. Eur J Gastroenterol Hepatol. 2014;26:1167–1175.PubMed Dainese R, Casellas F, Marine-Barjoan E, et al. Perception of lactose intolerance in irritable bowel syndrome patients. Eur J Gastroenterol Hepatol. 2014;26:1167–1175.PubMed
45.
Zurück zum Zitat Simren M, Tornblom H, Palsson OS, et al. Management of the multiple symptoms of irritable bowel syndrome. Lancet Gastroenterol Hepatol. 2017;2:112–122.PubMed Simren M, Tornblom H, Palsson OS, et al. Management of the multiple symptoms of irritable bowel syndrome. Lancet Gastroenterol Hepatol. 2017;2:112–122.PubMed
46.
Zurück zum Zitat Lin EC, Massey BT. Scintigraphy demonstrates high rate of false-positive results from glucose breath tests for small bowel bacterial overgrowth. Clin Gastroenterol Hepatol. 2016;14:203–208.PubMed Lin EC, Massey BT. Scintigraphy demonstrates high rate of false-positive results from glucose breath tests for small bowel bacterial overgrowth. Clin Gastroenterol Hepatol. 2016;14:203–208.PubMed
47.
Zurück zum Zitat Kee WJ, Seo M, Cho YH, et al. Prevalence of fructose malabsorption in patients with irritable bowel syndrome after excluding small intestinal bacterial overgrowth. J Neurogastroenterol Motil. 2018;24:307–316. Kee WJ, Seo M, Cho YH, et al. Prevalence of fructose malabsorption in patients with irritable bowel syndrome after excluding small intestinal bacterial overgrowth. J Neurogastroenterol Motil. 2018;24:307–316.
Metadaten
Titel
Diagnostic Utility of Carbohydrate Breath Tests for SIBO, Fructose, and Lactose Intolerance
verfasst von
Mercedes Amieva-Balmori
Enrique Coss-Adame
Nikilesh S. Rao
Brisa M. Dávalos-Pantoja
Satish S. C. Rao
Publikationsdatum
15.10.2019
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 5/2020
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-019-05889-9

Weitere Artikel der Ausgabe 5/2020

Digestive Diseases and Sciences 5/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.